Dermal Hypersensitivity Reaction Masquerading as Cellulitis: An Underrecognized Diagnostic Pitfall in the Inpatient Setting
K.V. and S.H. have no relevant disclosures. W.D. is a consultant for Pfizer, Incyte, Eli Lilly, and TWi Biotechnology, has research funding from Pfizer, Advanced Cell Diagnostics/Bio-techne, and AbbVie and receives licensing fees from EMD/Millipore/Sigma, all outside the submitted work. C.A.N. has received research grants from Boehringer Ingelheim and participated in an advisory board for work related to pustular psoriasis and palmoplantar pustulosis. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. The supplemental table is available on Mendeley: https://data.mendeley.com/datasets/txsjrf7p7f/2.
Authors
- William Damsky (ORCID: https://orcid.org/0000-0003-0975-4071)
- Caroline A. Nelson (ORCID: https://orcid.org/0000-0002-0863-6797)
- Kailyn Valido (ORCID: https://orcid.org/0000-0001-8981-6062)
- Suyeon Hong (ORCID: https://orcid.org/0000-0003-0200-7479)
Institutions
- Yale University (US)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1111/ijd.70169
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00